Detection of BRCA1/2 Large Genomic Rearrangement including BRCA1 Promoter-Region Deletions using Next-Generation Sequencing.
Germline mutations in BRCA1 and BRCA2 (BRCA1/2) have been conventionally analyzed by Sanger...
Read MoreFeb 25, 2020
Germline mutations in BRCA1 and BRCA2 (BRCA1/2) have been conventionally analyzed by Sanger...
Read MoreFeb 17, 2020
MLN4924 (pevonedistat) is a first-in-class NEDD8-activating enzyme (NAE) inhibitor in clinical...
Read MoreFeb 17, 2020
Given the poor prognosis of ovarian cancer and limited population-level strategies for early...
Read MoreFeb 17, 2020
Transforming growth factor-β, a cell secretion factor of the TGF-β superfamily, is involved in the...
Read MoreFeb 17, 2020
Clear cell ovarian carcinoma (CCOC) is an aggressive disease that often demonstrates resistance to...
Read MoreFeb 13, 2020
The tumor suppressor miR-34 family is transcriptionally induced by p53. Clinical significance of...
Read MoreFeb 13, 2020
Olaparib is the first poly(ADP-ribose) polymerase inhibitor approved as maintenance therapy of...
Read MoreFeb 13, 2020
This study aimed to investigate the influence of circular RNA PVT1 (circ-PVT1) on epithelial...
Read MoreFeb 13, 2020
Advanced epithelial ovarian cancer (EOC) is associated with dismal outcome and progression-free...
Read MoreFeb 13, 2020
Emerging evidence showed that long noncoding RNA (lncRNA) plays crucial roles in regulating...
Read MoreFeb 10, 2020
Ubiquitin-specific protease 14 (USP14) is one of the three proteasome-associated deubiquitinating...
Read MoreFeb 10, 2020
Epithelial ovarian cancer (EOC) is a leading cause of cancer-related mortality in the United...
Read MoreFeb 10, 2020
Paracrine signaling between tumor and surrounding stromal cells is critical for the maintenance of...
Read MoreFeb 10, 2020
Despite the promising anticancer effects of kinesin spindle protein (KSP) inhibition, functional...
Read MoreFeb 10, 2020
Ovarian cancer (OC) is the deadliest gynecological malignancy. The pathogenesis of molecular in...
Read MoreFeb 4, 2020
Ovarian cancer has the highest mortality rate among all gynecological cancers with its pathogenic...
Read MoreFeb 4, 2020
Fear of cancer recurrence (FCR) is a paramount concern among ovarian cancer survivors. Evidence...
Read MoreFeb 4, 2020
Long non-coding RNA (lncRNA) TTN antisense RNA 1 (TTN-AS1) was reported to be crucial modulators...
Read MoreFeb 4, 2020
BACKGROUND The prognosis of epithelial ovarian cancer (EOC) remains poor. Cause-specific survival...
Read MoreFeb 4, 2020
Most women with epithelial ovarian cancer (EOC) suffer from peritoneal carcinomatosis upon first...
Read More